Coronavirus Latest News

Australia news live: NSW to pay Chinese company Shenhua $100m to exit coalmine; Victoria to make mRNA Covid vaccine

State commits $50m to domestic manufacturing of cutting-edge vaccines; former Liberal staffer to ask Scott Morrison to fix ‘systemic coercive control’ in Parliament House. Follow live

We are waiting on the federal health authorities to provide more detail on the man in Queensland who attended hospital three days after receiving the Pfizer Covid-19 vaccine. But there is some important information to keep in mind in the meantime. He reportedly experienced blood clotting, Nine News said.

But there is nothing to suggest the man was hospitalised with the same type of serious but extremely rare clotting believed to be associated with the AstraZeneca vaccine. Most cases of these rare clots following vaccination with the AstraZeneca dose occurred in veins in the brain (a condition called cerebral venous sinus thrombosis, or CVST) though some occurred in other areas including veins to the abdomen (splanchnic vein thrombosis).

Symptoms in almost all cases develop between day four and 21, which doesn’t match with reports of the Queensland man reportedly attending hospital on day three. The man is no longer in hospital; he would likely still be there if he had serious and severe clotting.

Queensland deputy premier Steven Miles said:

It’s too early to say whether this incident is linked to the Pfizer vaccine.

The patient presented to a private hospital, is not currently admitted and any queries should be directed to the federal government. In Queensland, all adverse events in relation to the Covid-19 vaccines are reported to the Therapeutic Goods Administration. The TGA will then undertake an assessment and determine whether there is any clinical link to the vaccination.

South Australia reports two new cases of Covid-19, both in medi-hotels.

South Australian COVID-19 update 21/4/21. For more information, go to t.co/e4B14lR2Vd or contact the South Australian COVID-19 Information Line on 1800 253 787. pic.twitter.com/NYFPSpCCTe

Continue reading…

Read the original article at The Guardian

Related Articles

Back to top button
Close